D, A., M, R., DP, H., J, L., RB, S., TH, H., . . . WR, S. (2025). DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-Based Regimen Switch Strategy to Manage Integrase Inhibitor-Related Weight Gain. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 80(3), 602. https://doi.org/10.1093/cid/ciae449
Chicago Style (17th ed.) CitationD, Anderson, Ramgopal M, Hagins DP, Lee J, Simonson RB, Hsu TH, Xu P, Ahmad N, and Short WR. "DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-Based Regimen Switch Strategy to Manage Integrase Inhibitor-Related Weight Gain." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 80, no. 3 (2025): 602. https://doi.org/10.1093/cid/ciae449.
MLA (9th ed.) CitationD, Anderson, et al. "DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-Based Regimen Switch Strategy to Manage Integrase Inhibitor-Related Weight Gain." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 80, no. 3, 2025, p. 602, https://doi.org/10.1093/cid/ciae449.
